In:
Clinical Obesity, Wiley
Abstract:
Insulin receptor gene ( INSR ) mutations are a relatively rare and diverse cause of insulin resistance (IR), typically associated with a lean phenotype. However, we present a unique case of severe obesity and Type A severe IR syndrome in a patient with a heterozygous mutation of the INSR gene. Next Generation Sequencing (NGS) analysis was conducted to identify the genetic variant. A 16‐year‐old girl with severe obesity (BMI‐SDS +2.79) exhibited markedly elevated basal insulin levels ( 〉 800 mcU/L). Despite obesity being a known cause of hyperinsulinism, further investigation was pursued due to the severity of hyperinsulinaemia. A heterozygous nucleotide variant at the donor splicing site of intron 13 (c.2682 + 1G 〉 A) of the INSR gene was identified. This mutation was also present in the proband's normal‐weight mother and her two younger brothers with obesity. Metformin treatment provided limited benefits, but subsequent liraglutide therapy resulted in weight loss and decreased IR 3 months after initiation. Our findings suggest that obesity can exacerbate hyperinsulinaemia in individuals with an INSR gene mutation. Although INSR signalling defects play a minor role in the aetiology of IR, they should still be considered in the diagnostic pathway, particularly in severe phenotypes. Clinicians should not overlook the possibility of genetic causes in patients with obesity and IR, as they may require personalized management approaches.
Type of Medium:
Online Resource
ISSN:
1758-8103
,
1758-8111
Language:
English
Publisher:
Wiley
Publication Date:
2023
detail.hit.zdb_id:
2603811-0
